Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-053166
Filing Date
2021-04-21
Accepted
2021-04-21 16:15:34
Documents
1
Period of Report
2021-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2113676d1_form4.html 4  
1 FORM 4 tm2113676d1_form4.xml 4 4161
  Complete submission text file 0001104659-21-053166.txt   5569
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYEGATE PHARMACEUTICALS INC. 271 WAVERLY OAKS RD., STE 108 WALTHAM MA 02452
Business Address
Shapiro Aron (Reporting) CIK: 0001855207 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36672 | Film No.: 21841709